الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 176 |  |  |
| | | from | 176 | | |
Abstract
Diabetic neuropathies (DN) are the most prevalent chronic microvascular complications of diabetes (50% to 90%), not only a late complication but also one that can develop at any time during the disease. Diabetic neuropathies are classified into generalized symmetrical polyneuropathies including diabetic sensorimotor polyneuropathy (DSPN), acute painful DSPN, autonomic neuropathy (DAN), and focal/multifocal varieties including cranial neuropathy, mononeuritis, mononeuritis multiplex, radiculoplexus neuropathy, and entrapment neuropathy (EN).
Subclinical DN refers to the presence of nerve lesions attributable to DM in the absence of abnormal clinical manifestations but detectable by electro-diagnostic tests. Up to 50% of diabetic peripheral neuropathies may be asymptomatic. Early and precise detection of subclinical DN can aid in a better understanding of the pattern of pathophysiological changes, as well as looking for subclinical DN for possible prevention of late neuropathic complications such as diabetic foot ulcers (DFU) and infections, as well as providing appropriate care for patients suspected of developing DN.
The current study was conducted on 2 groups; the diabetic group consisted of 30 types 2 diabetic patients with a disease duration ≤ 5 years, and the control group consisted of 30 non-diabetic healthy subjects.